Latigo Biotherapeutics files initial beneficial ownership statement for SanofiPUBT·Aug 12 at 07:10 AMLTGO+3.63%SNY+1.26%
The Structural Pivot: How Niche Micro-Caps Navigate the Aggregation EraGlobal Report·Aug 11 at 05:13 AMATPC-2.78%UNCY+1.08%
Foresite’s James Tananbaum acquires 140,000 Latigo Biotherapeutics shares for $2.52 millionPUBT·Aug 10 at 07:00 PMLTGO+3.63%
Latigo Biotherapeutics adopts amended and restated bylaws tied to IPO closePUBT·Aug 10 at 03:04 PMLTGO+3.63%
